1. De Bolòs, Anna, Sureda-Gómez, Marta, Carreras-Caballé, Maria, Balsas, Patricia, Amador, Virginia. 2024. SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma. In Scientific reports, 14, 7863. doi:10.1038/s41598-024-58216-2. https://pubmed.ncbi.nlm.nih.gov/38570586/
2. Li, Peng, Wang, Weihua, Zhu, Baowei, Wang, Chenyu, Li, Qin. 2024. PRDX2 regulates stemness contributing to cisplatin resistance and metastasis in bladder cancer. In Environmental toxicology, 39, 2869-2880. doi:10.1002/tox.24153. https://pubmed.ncbi.nlm.nih.gov/38294069/
3. Agrawal-Singh, Shuchi, Isken, Fabienne, Agelopoulos, Konstantin, Dugas, Martin, Müller-Tidow, Carsten. 2011. Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor gene. In Blood, 119, 2346-57. doi:10.1182/blood-2011-06-358705. https://pubmed.ncbi.nlm.nih.gov/22207736/
4. Schneider, Markus, Szaumkessel, Marcin, Richter, Julia, Siebert, Reiner, Giefing, Maciej. . The PRDX2 gene is transcriptionally silenced and de novo methylated in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. In Blood, 123, 3672-4. doi:10.1182/blood-2014-02-553263. https://pubmed.ncbi.nlm.nih.gov/24904103/
5. Wang, Sen, Chen, Zheng, Zhu, Shoumin, Xu, Zekuan, El-Rifai, Wael. 2019. PRDX2 protects against oxidative stress induced by H. pylori and promotes resistance to cisplatin in gastric cancer. In Redox biology, 28, 101319. doi:10.1016/j.redox.2019.101319. https://pubmed.ncbi.nlm.nih.gov/31536951/
智鼠故事 
